Happy to share our new study in #Hepatology (May 1): we uncover how #liver cells "talk" to #immune cells to drive #MASH. Targeting TFF2 with #GalNAc-#siRNA ameliorates disease in vivo—highlighting a promising therapeutic path.
Read more: doi.org/10.1097/HEP.00…
English
